Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

27
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
27
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

213
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
213
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

29
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

266
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
266
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

19
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time to change our approach to presymptomatic treatment of Sturge-Weber syndrome.

Developmental medicine and child neurology·2024
Same author

Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program.

Epilepsia·2023
Same author

Genetic testing in the evaluation of individuals with clinical diagnosis of atypical Sturge-Weber syndrome.

American journal of medical genetics. Part A·2023
Same author

Gαq and hyper-phosphorylated ERK expression in Sturge-Weber syndrome leptomeningeal blood vessel endothelial cells.

Vascular medicine (London, England)·2018

Related Experiment Video

Updated: Aug 24, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

791

Updates on Sturge-Weber Syndrome.

SangEun Yeom1, Anne M Comi1,2,3,4

  • 1Department of Neurology and Developmental Medicine, Hugo Moser Kennedy Krieger Research Institute, Baltimore, MD (S.Y., A.M.C.).

Stroke
|October 20, 2022
PubMed
Summary

Sturge-Weber syndrome (SWS) is a rare neurovascular disorder affecting the brain, skin, and eyes. Research explores genetic links, including GNAQ mutations, and promising treatments like low-dose aspirin, cannabidiol, and Sirolimus.

Keywords:
Sturge-Weber syndromediagnosisseizuresstroketreatmentvascular malformations

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

528
A Unified Methodological Framework for Vestibular Schwannoma Research
08:43

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

7.5K

Related Experiment Videos

Last Updated: Aug 24, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

791
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

528
A Unified Methodological Framework for Vestibular Schwannoma Research
08:43

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

7.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Vascular Biology

Background:

  • Sturge-Weber syndrome (SWS) is a rare, non-inherited neurovascular disorder.
  • Characterized by abnormal vasculature in the brain, skin, and eye, leading to port-wine birthmarks, leptomeningeal angiomas, and glaucoma.
  • Associated with impaired brain perfusion, increasing risks of stroke, seizures, and neurological deficits.

Purpose of the Study:

  • To review the latest research advancements in Sturge-Weber syndrome.
  • To highlight current and potential future research directions for SWS.

Main Methods:

  • Review of recent retrospective studies and prospective drug trials.
  • Analysis of genetic research implicating somatic mutations.
  • Focus on therapeutic interventions and presymptomatic treatment strategies.

Main Results:

  • Identifies R183Q GNAQ somatic mutation as common in SWS; GNA11 and GNB2 mutations also implicated.
  • Low-dose aspirin and vitamin D show potential in retrospective studies.
  • Cannabidiol and Sirolimus demonstrate usefulness in prospective trials; presymptomatic aspirin and antiepileptics show promise in delaying seizures.

Conclusions:

  • Ongoing research is expanding the understanding of SWS genetics and pathophysiology.
  • Emerging treatments offer hope for improved management and outcomes in SWS patients.
  • Future research should focus on validating these treatments and exploring novel therapeutic targets.